Roman Butler Fullerton & CO Abiomed Inc Transaction History

Roman Butler Fullerton & CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 22, 2019	SELL	$250.96 - $284.94 $422,114 - $479,269	-1,682 Closed	0 $0
Q1 2019 Apr 24, 2019	SELL	$276.39 - $362.25 $206,739 - $270,963	-748 Reduced 30.78%	1,682 $480,000
Q4 2018 Feb 04, 2019	BUY	$281.08 - $444.25 $683,024 - $1.08 Million	2,430 New	2,430 $814,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Roman Butler Fullerton & CO, based on Form 13F filings with the SEC.

Stay updated on Roman Butler Fullerton & CO with notifications on news.